中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
5期
399-401
,共3页
蔡泓敏%赵冠人%冯端浩
蔡泓敏%趙冠人%馮耑浩
채홍민%조관인%풍단호
多重耐药基因%细胞色素P450酶2C19%基因多态性%氯吡格雷%基因芯片
多重耐藥基因%細胞色素P450酶2C19%基因多態性%氯吡格雷%基因芯片
다중내약기인%세포색소P450매2C19%기인다태성%록필격뢰%기인심편
multidrug resistance gene%cytochrome P450 2 C19%genetic polymorphism%clopidogrel%gene chip
目的:研究多重耐药基因(MDR1)及细胞色素P450酶2C19(CYP2C19)基因多态性对急性冠脉综合征( ACS)患者经皮冠状动脉介入( PCI)术后氯吡格雷疗效的影响。方法根据所测定的血栓弹力图MAADP结果,将进行PCI治疗的冠心病患者分为3组:A(MAADP >47)组、B(31≤MAADP≤47)组、C(MAADP <31)组;分别用基因芯片法和测序法,检测CYP2C19、MDR1基因多态性,比较不同组间基因多态性分布情况。结果各组患者在MDR1基因多态性未见明显差异(P>0.05),CYP2C19慢代谢基因型患者比例在 A 组明显高于另2组(P<0.05)。结论 CYP2C19基因多态性可以影响氯吡格雷的抗凝效果。
目的:研究多重耐藥基因(MDR1)及細胞色素P450酶2C19(CYP2C19)基因多態性對急性冠脈綜閤徵( ACS)患者經皮冠狀動脈介入( PCI)術後氯吡格雷療效的影響。方法根據所測定的血栓彈力圖MAADP結果,將進行PCI治療的冠心病患者分為3組:A(MAADP >47)組、B(31≤MAADP≤47)組、C(MAADP <31)組;分彆用基因芯片法和測序法,檢測CYP2C19、MDR1基因多態性,比較不同組間基因多態性分佈情況。結果各組患者在MDR1基因多態性未見明顯差異(P>0.05),CYP2C19慢代謝基因型患者比例在 A 組明顯高于另2組(P<0.05)。結論 CYP2C19基因多態性可以影響氯吡格雷的抗凝效果。
목적:연구다중내약기인(MDR1)급세포색소P450매2C19(CYP2C19)기인다태성대급성관맥종합정( ACS)환자경피관상동맥개입( PCI)술후록필격뢰료효적영향。방법근거소측정적혈전탄력도MAADP결과,장진행PCI치료적관심병환자분위3조:A(MAADP >47)조、B(31≤MAADP≤47)조、C(MAADP <31)조;분별용기인심편법화측서법,검측CYP2C19、MDR1기인다태성,비교불동조간기인다태성분포정황。결과각조환자재MDR1기인다태성미견명현차이(P>0.05),CYP2C19만대사기인형환자비례재 A 조명현고우령2조(P<0.05)。결론 CYP2C19기인다태성가이영향록필격뢰적항응효과。
Objective To study the relationship between multidrug re-sistance gene(MDR1)and cytochrome P450 2C19(CYP2C19)gene poly-morphisms and the effect of clopidogrel in patients with acute coronary syndrome ( ACS ) after undergoing percutaneous coronary intervention ( PCI ) .Methods The patients with ACS who were undergoing PCI were divided into three groups according to the result of MA ADP which tests by thromboelastogram ( TEG).Group A consists of patients with MA ADP >47, group B consists of patients with 31≤MAADP≤47 and group C con-sists of patients with MA ADP <31, respectively.The genotype of CYP2C19 is decided by gene chips hybridization and the genotype of MDR1 is decided by gene sequencing.Then the distribution of gene poly-morphism between were compared with different groups.Results There were no significantly differences among three groups in different genotype of MDR1( P>0.05 ).The proportion of patients with poor metabolism of CYP2C19 in group A was higher than the other two groups significantly ( P<0.05).Conclusion CYP2C19 gene polymorphisms affect the an-ticoagulant effect of clopidogrel.